Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Changes in ganglioside GM1 expression in glaucomic retina.

Literature DB >> 30019489

Changes in ganglioside GM1 expression in glaucomic retina.

Nate Pappenhagen^1,2, Denise M Inman².

Abstract

Entities: CellLine Chemical Disease Gene Species

Mesh：

Substances：
G(M1) Ganglioside

Year: 2018 PMID： 30019489 PMCID： PMC6129427 DOI： 10.1002/jnr.24273

Source DB: PubMed Journal: J Neurosci Res ISSN： 0360-4012 Impact factor: 4.164

× No keyword cloud information.

31 in total

1. GM1 ganglioside in Parkinson's disease: Results of a five year open study.

Authors: Jay S Schneider; Stephanie Sendek; Constantine Daskalakis; Franca Cambi
Journal: J Neurol Sci Date: 2010-03-05 Impact factor: 3.181

2. Ganglioside GM1 induces phosphorylation of mutant huntingtin and restores normal motor behavior in Huntington disease mice.

Authors: Alba Di Pardo; Vittorio Maglione; Melanie Alpaugh; Melanie Horkey; Randy S Atwal; Jenny Sassone; Andrea Ciammola; Joan S Steffan; Karim Fouad; Ray Truant; Simonetta Sipione
Journal: Proc Natl Acad Sci U S A Date: 2012-02-13 Impact factor: 11.205

3. Metabolic vulnerability disposes retinal ganglion cell axons to dysfunction in a model of glaucomatous degeneration.

Authors: Selva Baltan; Denise M Inman; Camelia A Danilov; Richard S Morrison; David J Calkins; Philip J Horner
Journal: J Neurosci Date: 2010-04-21 Impact factor: 6.167

4. Optic nerve damage in human glaucoma. II. The site of injury and susceptibility to damage.

Authors: H A Quigley; E M Addicks; W R Green; A E Maumenee
Journal: Arch Ophthalmol Date: 1981-04

5. The number of people with glaucoma worldwide in 2010 and 2020.

Authors: H A Quigley; A T Broman
Journal: Br J Ophthalmol Date: 2006-03 Impact factor: 4.638

6. Progressive ganglion cell degeneration precedes neuronal loss in a mouse model of glaucoma.

Authors: Brian P Buckingham; Denise M Inman; Wendi Lambert; Ericka Oglesby; David J Calkins; Michael R Steele; Monica L Vetter; Nicholas Marsh-Armstrong; Philip J Horner
Journal: J Neurosci Date: 2008-03-12 Impact factor: 6.167

7. Formation of toxic fibrils of Alzheimer's amyloid beta-protein-(1-40) by monosialoganglioside GM1, a neuronal membrane component.

Authors: Takuma Okada; Masaki Wakabayashi; Keisuke Ikeda; Katsumi Matsuzaki
Journal: J Mol Biol Date: 2007-05-31 Impact factor: 5.469

Changes in ganglioside GM1 expression in glaucomic retina.

1. GM1 ganglioside in Parkinson's disease: Results of a five year open study.

2. Ganglioside GM1 induces phosphorylation of mutant huntingtin and restores normal motor behavior in Huntington disease mice.

3. Metabolic vulnerability disposes retinal ganglion cell axons to dysfunction in a model of glaucomatous degeneration.

4. Optic nerve damage in human glaucoma. II. The site of injury and susceptibility to damage.

5. The number of people with glaucoma worldwide in 2010 and 2020.

6. Progressive ganglion cell degeneration precedes neuronal loss in a mouse model of glaucoma.

7. Formation of toxic fibrils of Alzheimer's amyloid beta-protein-(1-40) by monosialoganglioside GM1, a neuronal membrane component.

8. Markers for detergent-resistant lipid rafts occupy distinct and dynamic domains in native membranes.

9. Retinal ganglion cell degeneration is topological but not cell type specific in DBA/2J mice.

Review 10. The nerve growth factor signaling and its potential as therapeutic target for glaucoma.

Review 1. Gangliosides in nervous system development, regeneration, and pathologies.